#ask doctors questions
Questions to Ask Your Doctor About the Oncotype DX Breast Cancer Test
The Oncotype DX breast cancer test is a genomic test that may help guide treatment decisions for patients with non-invasive breast cancer, often referred to as ductal carcinoma in situ (DCIS), and help early-stage invasive breast cancer patients with estrogen receptor -positive (ER+) disease evaluate if they will benefit from chemotherapy. The decision whether or not to order the Oncotype DX test is one that you and your doctor should make together.
%img src=”http://www.mybreastcancertreatment.org/en-US/IsOnctoypeDXForYou/%3C/p%3E%0D%0A%3Cp%3E%25img%20src=”http://www.mybreastcancertreatment.org/en-US/IsOnctoypeDXForYou/%3C/p%3E%0D%0A%3Cp%3E/media/MBCT/RedesignImages/Invasive-DoctorDiscussion.png?h=121 w=96″ /% Download and Print the Doctor Discussion Guide for Early Stage Invasive Breast Cancer for a list of questions to help you discuss the Oncotype DX test with your doctor.
Questions for Patients with Ductal Carcinoma In Situ (DCIS) Stage 0 Breast Cancer
- I understand that my breast cancer is non-invasive DCIS (stage 0). What are the chances of my cancer coming back after surgery as DCIS or invasive breast cancer?
Questions for Patients With Early-Stage Invasive Breast Cancer (Stage I-IIIa)
- What stage is my breast cancer and what are the chances of my cancer coming back after surgery?